BTLA antibody (AA 111-160)
Quick Overview for BTLA antibody (AA 111-160) (ABIN6747889)
Target
See all BTLA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 111-160
-
Specificity
- Human BTLA
-
Predicted Reactivity
- Percent identity by BLAST analysis: Human (100%).
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa111-160 of human BTLA (Q7Z6A9, NP_861445). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey (100%), Marmoset (91%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- BTLA (B and T Lymphocyte Associated (BTLA))
-
Alternative Name
- BTLA / CD272
-
Background
-
Name/Gene ID: BTLA
Synonyms: BTLA, BTLA1, B and T lymphocyte associated, CD272, B and T lymphocyte attenuator, B- and T-lymphocyte attenuator, CD272 antigen -
Gene ID
- 151888
-
NCBI Accession
- NP_861445
-
UniProt
- Q7Z6A9
-
Pathways
- Cancer Immune Checkpoints
Target
-